Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity - PubMed (original) (raw)
. 1998 Jan 15;160(2):877-83.
Affiliations
- PMID: 9551924
Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity
J Hesselgesser et al. J Immunol. 1998.
Abstract
The CXCR4 chemokine receptor has been shown to respond to the C-X-C chemokine stromal-derived factor (SDF-1) and has recently been shown to be an important coreceptor for HIV-1 infection. In the present paper we have tested a number of human lymphocyte cell lines, including Jurkat, HUT78, CEM, and Sup-T1 for the presence of CXCR4 receptors. We found that these T cell lines bind SDF-1alpha and SDF-1beta with high affinity. The CXCR4 Ab 12G5 inhibited both SDF-1 binding and HIV-1LAI-mediated fusion of CEM. Scatchard analysis revealed the presence of approximately 150,000 SDF-1alpha-binding sites per cell with a Kd between 5 and 10 nM. Cross-competition experiments using unlabeled SDF-1alpha and SDF-1beta revealed that both chemokines are equally capable of displacing their radiolabeled counterparts. Internalization studies with [125]I-SDF-1alpha revealed that Jurkat cells internalized greater than 90% of the ligand by 2 h at 37 degrees C. SDF-1alpha was also chemotactic for Jurkat cells and caused an increase in the rate of extracellular acidification that was half-maximal at 18 nM SDF-1alpha and could be inhibited by pretreatment with the SDF-1 proteins, pertussis toxin, or the Ab 12G5. Finally, SDF-1alpha also caused an increase in the cytosolic Ca2+ concentration in Sup-T1 cells that was abolished by preincubating the cells with pertussis toxin or PMA and inhibited by the Ab 12G5. This molecular characterization of CXCR4 receptors should prove useful in clarifying receptor interaction with SDF-1 proteins and with HIV-1 glycoprotein, with the ultimate aim of targeting the viral interaction for therapeutic intervention.
Similar articles
- Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
Mochizuki H, Matsubara A, Teishima J, Mutaguchi K, Yasumoto H, Dahiya R, Usui T, Kamiya K. Mochizuki H, et al. Biochem Biophys Res Commun. 2004 Jul 30;320(3):656-63. doi: 10.1016/j.bbrc.2004.06.013. Biochem Biophys Res Commun. 2004. PMID: 15240098 - Solubilization of the chemokine receptor CXCR4.
Staudinger R, Bandres JC. Staudinger R, et al. Biochem Biophys Res Commun. 2000 Jul 21;274(1):153-6. doi: 10.1006/bbrc.2000.3109. Biochem Biophys Res Commun. 2000. PMID: 10903911 - A CXC chemokine SDF-1/PBSF: a ligand for a HIV coreceptor, CXCR4.
Nagasawa T, Tachibana K, Kawabata K. Nagasawa T, et al. Adv Immunol. 1999;71:211-28. doi: 10.1016/s0065-2776(08)60403-4. Adv Immunol. 1999. PMID: 9917914 Review. No abstract available. - Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4).
Oishi S, Fujii N. Oishi S, et al. Org Biomol Chem. 2012 Aug 14;10(30):5720-31. doi: 10.1039/c2ob25107h. Epub 2012 Apr 19. Org Biomol Chem. 2012. PMID: 22517031 Review.
Cited by
- Genotype-phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4WHIM variants.
Zmajkovicova K, Pawar S, Maier-Munsa S, Maierhofer B, Wiest I, Skerlj R, Taveras AG, Badarau A. Zmajkovicova K, et al. Genes Immun. 2022 Sep;23(6):196-204. doi: 10.1038/s41435-022-00181-9. Epub 2022 Sep 12. Genes Immun. 2022. PMID: 36089616 Free PMC article. - Determination of G-protein-coupled receptor oligomerization by molecular brightness analyses in single cells.
Işbilir A, Serfling R, Möller J, Thomas R, De Faveri C, Zabel U, Scarselli M, Beck-Sickinger AG, Bock A, Coin I, Lohse MJ, Annibale P. Işbilir A, et al. Nat Protoc. 2021 Mar;16(3):1419-1451. doi: 10.1038/s41596-020-00458-1. Epub 2021 Jan 29. Nat Protoc. 2021. PMID: 33514946 - Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonists.
Işbilir A, Möller J, Arimont M, Bobkov V, Perpiñá-Viciano C, Hoffmann C, Inoue A, Heukers R, de Graaf C, Smit MJ, Annibale P, Lohse MJ. Işbilir A, et al. Proc Natl Acad Sci U S A. 2020 Nov 17;117(46):29144-29154. doi: 10.1073/pnas.2013319117. Epub 2020 Nov 4. Proc Natl Acad Sci U S A. 2020. PMID: 33148803 Free PMC article. - Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration.
Jin J, Zhao Q. Jin J, et al. Theranostics. 2020 May 15;10(14):6231-6244. doi: 10.7150/thno.45219. eCollection 2020. Theranostics. 2020. PMID: 32483450 Free PMC article. Review. - Functional mimetic of the G-protein coupled receptor CXCR4 on a soluble antibody scaffold.
Koksal AC, Pennini ME, Marelli M, Xiao X, Dall'Acqua WF. Koksal AC, et al. MAbs. 2019 May/Jun;11(4):725-734. doi: 10.1080/19420862.2019.1596703. Epub 2019 Apr 16. MAbs. 2019. PMID: 30900513 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous